+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inhalation Drugs Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923098
The global inhalation drugs market size was estimated to be USD 33.61 billion in 2023 and is expected to reach at USD 68.66 billion by 2034 with a CAGR of 6.71% during the forecast period 2024-2034. Growing prevalence of respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), & cystic fibrosis, rising prevalence of non-respiratory diseases such as Parkinson’s disease & diabetes, increasing focus on the development of inhalable medications to facilitate administration by manufacturers, surge in advancements in inhalable drugs, growing research & development activities, rising need for efficient therapies, and increasing approval of inhalation drugs by regulatory bodies are some of the key factors boosting the market growth.

Increasing approval of inhalation drugs by regulatory bodies is predicted to boost the market growth during the forecast period. Advanced inhalation therapy includes the utilization of surfactant carriers, nanocrystals, and micro and nanoparticles. Consequently, research is being undertaken on small molecules to create novel inhalable medications. These developments in inhalation therapies bring about enhanced systemic drug availability, offer greater convenience compared to invasive approaches, improve drug interactions, and minimize toxic effects. The reformulation of existing non-inhaled compounds into inhalable forms for improved drug delivery is opening up new growth prospects for market participants. For instance, in January 2023, AstraZeneca has obtained clearance from the U.S. Food and Drug Administration for Airsupra, an inhalation aerosol containing albuterol and budesonide. Airsupra is designed to lower the chances of asthma exacerbations in individuals who are 18 years and older. This inhalable medication is the result of a collaborative effort between AstraZeneca and Avillion.

By drug class, aerosols was the highest revenue-grossing segment in the global inhalation drugs market in 2023 owing to the rising focus on development of inhalable products that are user-friendly & efficient and surge in launch of new products. Additionally, dry powder formulation is predicted to boost the market growth during the forecast period owing to its superior effectiveness & more favorable outcomes when compared to alternative forms, a diverse array of products & a robust development pipeline for this formulation, and increasing regulatory approvals. For instance, in May 2022, The United Therapeutics Corporation has disclosed that the FDA has given its approval for Tyvaso DPI, an inhalation powder intended for the treatment of pulmonary hypertension and pulmonary arterial hypertension associated with interstitial lung diseases.

By application, respiratory diseases was the highest revenue-grossing segment in the global inhalation drugs market in 2023 owing to the growing adoption of inhalable medications for managing chronic respiratory conditions such as COPD, asthma, & bronchospasm, surge in efforts for the development of combination therapies., and rising approvals by regulatory authorities. For instance, in March 2022, Mylan Pharmaceuticals, a subsidiary of Viatris Inc., has secured FDA approval for its Abbreviated New Drug Application (ANDA) for Breyna inhalation aerosol, a generic alternative to Symbicort. Breyna is intended for patients with asthma and chronic obstructive pulmonary disease (COPD). Additionally, non-respiratory diseases is predicted to grow at fastest CAGR during the forecast period owing to increasing prevalence of diabetes and rising introduction of inhalers as a cost-effective alternative therapy by manufacturers.

By distribution channel, retail pharmacies was the highest revenue-grossing segment in the global inhalation drugs market in 2023 owing to the rising healthcare expenditure, elevated sales of generic drugs, and growing regulatory approvals. For instance, in March 2022, The US Food and Drug Administration (FDA) has given its approval for the first generic version of Symbicort, an inhalation aerosol containing budesonide and formoterol fumarate dihydrate. This medication is designed for the treatment of two prevalent pulmonary conditions, namely asthma in patients aged six years and older. Additionally, online pharmacies is anticipated to grow at fastest CAGR during the forecast period. Online pharmacies provide patients with accessibility and convenience. As internet usage continues to rise, the number of individuals buying products from online pharmacies is rapidly growing.

North America region is anticipated for the highest revenue share during the forecast period owing to the rising prevalence of respiratory disorders, surge in awareness programs conducted by governments, organizations, & companies to improve treatment options for COPD, growing research & development activities. For instance, in May 2023, Zambon has declared the successful enrolment completion in its two critical Phase 3 trials. These studies are structured to assess the safety and effectiveness of Liposomal Cyclosporine A for Inhalation (L-CsA-i) as a treatment for Bronchiolitis Obliterans Syndrome (BOS) in adults who have undergone single lung (BOSTON-1) or double lung (BOSTON-2) transplantation. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing healthcare infrastructure, rising patient awareness, surge in medical tourism, and growing regulatory approvals. For instance, in August 2022, Lupin has been granted FDA approval for its Formoterol Fumarate Inhalation Solution, which is employed in the management of symptoms associated with chronic obstructive pulmonary disease. The company has received the US Food and Drug Administration's (USFDA) endorsement for the generic variant of Mylan Specialty's Perforomist Inhalation Solution.

Segmentation: Inhalation Drugs Market Report 2023 - 2034

Inhalation Drugs Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Dry Powder Formulation
  • Aerosol
  • Spray

Inhalation Drugs Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Non-Respiratory Disease
  • Respiratory Diseases

Inhalation Drugs Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacies
  • Online Pharmacies

Inhalation Drugs Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Inhalation Drugs Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Inhalation Drugs Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Segment Opportunity Analysis
7.2. Dry Powder Formulation
7.2.1. Dry Powder Formulation Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Aerosol
7.3.1. Aerosol Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Spray
7.4.1. Spray Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Inhalation Drugs Market: Application Estimates & Trend Analysis
8.1. Application Segment Opportunity Analysis
8.2. Non-Respiratory Disease
8.2.1. Non-Respiratory Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Respiratory Diseases
8.3.1. Respiratory Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Inhalation Drugs Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Online Pharmacies
9.3.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Inhalation Drugs Market
11.1. North America Inhalation Drugs Market
11.1.1. North America Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Inhalation Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.1.4. North America Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.5. North America Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Inhalation Drugs Market
11.2.1. U.S. Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Inhalation Drugs Market
11.3.1. Canada Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Inhalation Drugs Market
12.1. Europe Global Inhalation Drugs Market
12.1.1. Europe Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Inhalation Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Inhalation Drugs Market
12.2.1. Germany Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Inhalation Drugs Market
12.3.1. UK Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.3. UK Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.4. UK Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Inhalation Drugs Market
12.4.1. France Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.4.3. France Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.4. France Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Inhalation Drugs Market
12.5.1. Spain Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Inhalation Drugs Market
12.6.1. Italy Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Inhalation Drugs Market
12.7.1. Rest of Europe Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Inhalation Drugs Market
13.1. Asia Pacific Global Inhalation Drugs Market
13.1.1. Asia Pacific Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Inhalation Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Inhalation Drugs Market
13.2.1. Japan Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Inhalation Drugs Market
13.3.1. China Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.3. China Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.4. China Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Inhalation Drugs Market
13.4.1. India Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.3. India Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.4. India Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Inhalation Drugs Market
13.5.1. South Korea Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Inhalation Drugs Market
13.6.1. Australia Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Inhalation Drugs Market
13.7.1. Rest of Asia Pacific Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Inhalation Drugs Market
14.1. Latin America Global Inhalation Drugs Market
14.1.1. Latin America Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Inhalation Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Inhalation Drugs Market
14.2.1. Brazil Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Inhalation Drugs Market
14.3.1. Mexico Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Inhalation Drugs Market
14.4.1. Argentina Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Inhalation Drugs Market
14.5.1. Rest of Latin America Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Inhalation Drugs Market
15.1. MEA Global Inhalation Drugs Market
15.1.1. MEA Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Inhalation Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Inhalation Drugs Market
15.2.1. GCC Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Inhalation Drugs Market
15.3.1. South Africa Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Inhalation Drugs Market
15.4.1. Rest of MEA Inhalation Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Inhalation Drugs Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Inhalation Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Inhalation Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Cipla Inc.
17.2. Zambon
17.3. Sanofi
17.4. Mylan Pharmaceuticals
17.5. AstraZeneca
17.6. GSK plc.
17.7. Lupin Pharmaceutical Inc
17.8. Viatris Inc.
17.9. AstraZeneca
17.10. Vectura Group Ltd
17.11. Mundipharma International
17.12. Boehringer Ingelheim International GmbH
17.13. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Cipla Inc.
  • Zambon
  • Sanofi
  • Mylan Pharmaceuticals
  • AstraZeneca
  • GSK plc.
  • Lupin Pharmaceutical Inc
  • Viatris Inc.
  • AstraZeneca
  • Vectura Group Ltd
  • Mundipharma International
  • Boehringer Ingelheim International GmbH

Table Information